GlassScriptPhysician profile
Vinod Karthik Ravikumar
NPI 1952806655
$1,719.12
in general payments reported to CMS, 2019-2025
10 companies · $757 in 2025
The $757 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $203 · 2023: $320 · 2024: $439 · 2025: $757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,516.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $631.70 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $243.32 | 2024-2025 | Tezspire |
| Nevro Corp. | $233.50 | 2023 | Senza |
| Emd Serono, INC. | $203.00 | 2022 | |
| Lilly USA, LLC | $123.61 | 2025 | Kisunla |
| Pfizer INC. | $110.61 | 2024-2025 | |
| Abbott Laboratories | $71.16 | 2025 | Eterna |
| Sk Life Science, INC. | $49.82 | 2024 | Xcopri |
| Boston Scientific Corporation | $32.27 | 2024 | General Dbs |
| Ucb, INC. | $20.13 | 2023 | Briviact |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinod Ravikumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.